Curcumin Treatment Abrogates Endoplasmic Reticulum Retention and Aggregation-Induced Apoptosis Associated with Neuropathy-Causing Myelin Protein Zero–Truncating Mutants

作者: Mehrdad Khajavi , Ken Inoue , Wojciech Wiszniewski , Tomoko Ohyama , G. Jackson Snipes

DOI: 10.1086/497541

关键词: Frameshift mutationBiochemistryCell biologyMyelinCytoplasmMutationMutantPeripheral neuropathyEndoplasmic reticulumMyelin protein zeroBiology

摘要: Mutations in MPZ, the gene encoding myelin protein zero (MPZ), major constituent of peripheral myelin, can cause adult-onset, inherited neuropathy Charcot-Marie-Tooth disease, as well more severe, childhood-onset Dejerine-Sottas and congenital hypomyelinating neuropathy. Most MPZ-truncating mutations associated with severe forms result premature termination codons within terminal or penultimate exons that are not subject to nonsense-mediated decay stably translated into mutant proteins potential dominant-negative activity. However, some truncating at 3′ end MPZ escape pathway a mild phenotype. We examined functional properties escaped decay, we found frameshift disease an intracellular accumulation proteins, primarily endoplasmic reticulum (ER), which induces apoptosis. Curcumin, chemical compound derived from curry spice tumeric, releases ER-retained mutants cytoplasm accompanied by lower number apoptotic cells. Our findings suggest curcumin treatment is sufficient relieve toxic effect aggregation-induced apoptosis may potentially have therapeutic role treating selected neuropathies.

参考文章(36)
K. R. Brunden, Yungao Ding, The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. Journal of Biological Chemistry. ,vol. 269, pp. 10764- 10770 ,(1994) , 10.1016/S0021-9258(17)34125-X
Donatella D’Urso, Reinhard Prior, Regine Greiner–Petter, Anneke A. W. M. Gabreëls–Festen, Hans Werner Müller, Overloaded Endoplasmic Reticulum–Golgi Compartments, a Possible Pathomechanism of Peripheral Neuropathies Caused by Mutations of the Peripheral Myelin Protein PMP22 The Journal of Neuroscience. ,vol. 18, pp. 731- 740 ,(1998) , 10.1523/JNEUROSCI.18-02-00731.1998
Suzanne M. Deschênes, Jessica L. Walcott, Tamara L. Wexler, Steven S. Scherer, Kenneth H. Fischbeck, Altered Trafficking of Mutant Connexin32 The Journal of Neuroscience. ,vol. 17, pp. 9077- 9084 ,(1997) , 10.1523/JNEUROSCI.17-23-09077.1997
K. M. Dickson, J. J. M. Bergeron, I. Shames, J. Colby, D. T. Nguyen, E. Chevet, D. Y. Thomas, G. J. Snipes, Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for “gain-of-function” ER diseases Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 9852- 9857 ,(2002) , 10.1073/PNAS.152621799
Yuanlin Song, N. D. Sonawane, Danieli Salinas, Liman Qian, Nicoletta Pedemonte, Luis J. V. Galietta, A. S. Verkman, Evidence against the Rescue of Defective ΔF508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse Models Journal of Biological Chemistry. ,vol. 279, pp. 40629- 40633 ,(2004) , 10.1074/JBC.M407308200
Ken Inoue, Mehrdad Khajavi, Tomoko Ohyama, Shin-ichi Hirabayashi, John Wilson, James D Reggin, Pedro Mancias, Ian J Butler, Miles F Wilkinson, Michael Wegner, James R Lupski, Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nature Genetics. ,vol. 36, pp. 361- 369 ,(2004) , 10.1038/NG1322
Bernd Rautenstrauβ, Eva Nelis, Holger Grehl, Rudolf A. Pfeiffer, Christine Van Broeckhoven, Identification of a de novo insertional mutation in P0 in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. Human Molecular Genetics. ,vol. 3, pp. 1701- 1702 ,(1994) , 10.1093/HMG/3.9.1701
Kiyoshi Hayasaka, Masato Himoro, Yukio Sawaishi, Kenji Nanao, Tsutomu Takahashi, Goro Takada, Garth A. Nicholson, Robert A. Ouvrier, Nobutada Tachi, De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nature Genetics. ,vol. 5, pp. 266- 268 ,(1993) , 10.1038/NG1193-266
Mary C. Ryan, Eric M. Shooter, Lucia Notterpek, Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiology of Disease. ,vol. 10, pp. 109- 118 ,(2002) , 10.1006/NBDI.2002.0500